Össur hf: Össur’s total share capital following completion of capital reduction of 2,000,000 shares
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Össur hf: Össur’s total share capital following completion of capital reduction of 2,000,000 shares

Announcement no. 11/2023

29 March 2023

Registration of capital reduction completed

Reference is made to Össur’s announcement no. 09/2023 published 10 March 2023.

The capital reduction of ISK 2,000,000 nominal value was registered with the Icelandic Register of Enterprises today. 2,000,000 treasury shares with a nominal value of ISK 1 each were cancelled.

The shares cancelled are expected to be removed from trading on Nasdaq Copenhagen with effect from 31 March 2023.

Össur’s total share capital

According to Article 19 of the Icelandic Act on Issuers’ Disclosure Requirements and Flagging Obligations, an issuer shall make public, as soon as possible, the total number of shares and voting rights following a decrease in share capital.

Össur’s total share capital is now ISK 421,000,000 nominal value divided into the same number of shares with a nominal value of ISK 1 each following the share capital reduction referred to above.

Össur currently holds 701,647 treasury shares that do not carry voting rights.

Further information

Edda Lára Lúðvígsdóttir, Investor Relations Director, [email protected], +354 844 4759

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors

About Össur

Össur (Nasdaq Copenhagen: OSSR) is a leading global provider of innovative mobility solutions that help people live a Life Without Limitations®. For over 50 years, Össur has had a strong purpose rooted in positively impacting people’s health and well-being. A recognized “Technology Pioneer”, Össur focuses on improving people’s mobility through the delivery of solutions that advance patient care. Significant investment in research and development has led to over 2,000 patents, award-winning designs, successful clinical outcomes, and steady growth. Össur is committed to sustainable business practices and is signatory to the UN Global Compact, UN Women’s Empowerment Principles, and contributes to the UN Sustainable Development Goals. Össur operates globally and has around 4,000 employees. www.ossur.com

Nyheter om Embla Medical

Läses av andra just nu

Om aktien Embla Medical

Senaste nytt